Dr.Reddy's is an India-based multinational pharmaceutical company that manufactures and markets medicines, active pharmaceutical ingredients and intermediates.
Dr. Reddy's Laboratories: Pharma stock hype explained
Dr. Reddy's Laboratories, an Indian pharma company, is gaining attention due to strong financials, volatile stock, and presence in generics market. The company is expanding globally and competing with major pharma players.
Dr. Reddy's acquires J&J's Stugeron for $50.5 million
Dr. Reddy's Laboratories acquires Johnson & Johnson's anti-vertigo drug Stugeron for $50.5 million, expanding its CNS portfolio in India and emerging markets.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.